Researchers describe pegcetacoplan, a new class of medication, as the “closest thing to a cure” for the rare, severe kidney disease C3 glomerulopathy.

A new study suggests treatment-resistant depression may be rooted in the immune system. Trauma, stress biology, and ...

New research suggests that a severe and specific form of depression involves a systemic disruption linking the immune system ...

A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering ...

Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 Bio Phase 2 basket trial ...

Dr. Lal PathLabs (DLPL) has announced the launch of complement testing laboratory, strengthening autoimmune diagnostics. This ...

It is estimated that nearly 70 %of autoimmune patients in India are women.

A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering research and clinical leadership from University of Iowa Health Care Stead ...

Dr. Lal PathLabs, one of India's leading diagnostic networks, today announced the launch of India's first dedicated ...

Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

Even by conservative assumptions that 5 to 10 per cent of infected individuals develop long Covid, India today may be home to ...